Cargando…
A new gamboge derivative Compound 2 inhibits cancer stem-like cells via suppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma
Cancer stem-like cells represent a population of tumour-initiating cells that lead to the relapse and metastasis of cancer. Conventional anti-cancer therapeutic drugs are usually ineffective in eliminating the cancer stem-like cells. Therefore, new drugs or therapeutic methods effectively targeting...
Autores principales: | Deng, Rongxin, Wang, Xu, Liu, Yang, Yan, Ming, Hanada, Sayaka, Xu, Qin, Zhang, Jianjun, Han, Zeguang, Chen, Wantao, Zhang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117555/ https://www.ncbi.nlm.nih.gov/pubmed/24112466 http://dx.doi.org/10.1111/jcmm.12129 |
Ejemplares similares
-
Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
por: Vatte, Chittibabu, et al.
Publicado: (2017) -
The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma
por: He, Di, et al.
Publicado: (2009) -
Caveolin‐1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma
por: Lu, Tingwei, et al.
Publicado: (2021) -
EGFR Mutations in Head and Neck Squamous Cell Carcinoma
por: Nair, Sindhu, et al.
Publicado: (2022) -
Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma
por: Xu, Xing, et al.
Publicado: (2021)